Skip to content

Clinical trials

Phase 1 Migraine Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 1 Country / region: United States Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20086
20112
20122
20133
20143
20153
20163
20175
20186
20194
20201
20215
20221
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting3
Terminated3
Enrolling by invitation1
Withdrawn1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Amgen5
Pfizer5
H. Lundbeck A/S3
Yale University3
Zosano Pharma Corporation3
Acorda Therapeutics2
GlaxoSmithKline2
Mayo Clinic2
NuPathe Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders54
Headache4
Migraine with Aura3
Migraine without Aura3
Inflammation2
Asthma1
Cluster Headache1
Epilepsy1
Lacerations1
Pain1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.